CN105616425A - Medicinal composition for treating pulpitis - Google Patents

Abstract

The invention discloses a medicinal composition for treating pulpitis. The medicinal composition is prepared from the following medicinal materials in parts by weight: 20-40 parts of nicotinic acid, 10-20 parts of dibazolum, 1-3 parts of chlortrimeton, 0.5-1.5 parts of hexadecadrol, 15-30 parts of phenytoin sodium, 5-10 parts of vitamin, and 200-400 parts of metronidazole. According to the medicine, the components have good synergistic effects, so that the effects of the medicine for resisting inflammation and histamine and inhibiting anaerobic bacteria are obviously enhanced, and meanwhile, the medicine also has the good analgesic effect, and enables edema and inflammation of the pulp tissue to be rapidly controlled and eliminated, so that the pressure inside the dental pulp cavity of a patient is rapidly alleviated, and further, the pain of the patient is alleviated. The medicine is suitable for treating acute pulpitis and apical periodontitis, and also has good curative effects for supraorbital neuralgia and cerebrovascular tension increased type migraine.

Description

A kind of pharmaceutical composition for pulpitis

Technical field

The present invention relates to medicinal preparation, specifically a kind of pharmaceutical composition suitable in pulpitis.

Technical background

Pulp tissue's (nerve, blood vessel, lymph, connective tissue) of dental caries is inflamed, and is referred to as pulpitis. Owing to tooth is bone tissue, wherein in tiny bone cavity, there are abundant blood vessel, nervous tissue. Therefore once Pulpal pathosis, oozing out of inflammation cannot be discharged, may result in and make patient's pain violent, insufferable. The general clinical manifestation of pulpitis is: spontaneous pain, and paroxysmal is aggravated, intermittent attack. Being characterized in: early pain duration of seizure is short, and later time is longer, along with PD, panic attacks time length, remission time are short, or even last without the catabasis; Night, pain was than weight on daytime, and when putting down sleeping, pain becomes apparent from; Early stage caloric stimulation all can cause pain to increase the weight of; Another distinguishing feature during pulpitis pain is that pain can not position, often along nervi trigeminus areal area homonymy maxillary and mandibular teeth tooth and close on position radiation, patient usually not can designate that the accurate location of cacodontia. The treatment of current pulpitis is more complicated, generally at least needs to cure 34 times. Generally adopt following therapeutic scheme, first carry out pulp sedation treatment, to early stage pulpitis, after removing soft rotten dentine gently, insert with Oleum Caryophylli cotton pellet and in cavity, pacify dental pulp, to analgesia, antiinflammatory, and preserve pulp vitality as far as possible; When pulp sedation Endodontic failure or closure purulent pulpitis, capping should be bored by timely dental drill, make pus obtain drain, decompression pain relieving (i.e. marrow drain); After above-mentioned treatment, after remission, the medicine that reselection is suitable, by the activity destruction of pulp tissue, subsequently by Intradental nerve tissue extracting, and each root pipe of tooth is expanded, after sterilized, insert various filler. As can be seen here, in traditional pulpitis treatment, patient need to stand longer pain, and therapeutic process is loaded down with trivial details, and doctor patient is both needed to put into substantial amounts for the treatment of time.

Summary of the invention

It is an object of the invention to provide a kind of pharmaceutical composition that can alleviate, release pulpitis patient suffering conveniently and efficiently, and can effectively control and eliminate pulpitis disease.

The object of the present invention is achieved like this:

Pharmaceutical composition of the present invention, including the component of following weight portion:

20 40 parts of nicotinic acid, bendazol 10 20 parts, chlorphenamine 13 parts, dexamethasone 0.5 1.5 parts, phenytoin Sodium 15 30 parts, Wei Shengsushi 5 10 parts, metronidazole 200 400 parts.

Good synergism can be produced between medicine each component of the present invention, make antiinflammatory, antihistaminic that medicine has and suppress the effect of anaerobe to obtain significant enhancing, and medicine has again good analgesic effect simultaneously, and the edema of pulp tissue, inflammation can be made to be controlled rapidly and eliminate, the pressure in patient's pulp cavity is made to be able to rapid alleviation, thus alleviating the pain of patient further. The present invention is equipped with vitamin medicaments component again, can supplement the nutrients for dental nerve in time, and pulp tissue's quick recovery can be promoted and recover normal physiological function early.

Medicine of the present invention can effectively control and eliminate the pulpitis symptom of general pulpitis patient. General clothes for patients medicine of the present invention is cured for 57 days substantially. The present inventor goes through the clinical practice of decades, and more than ten thousand name patients have been carried out clinical verification. Medicine of the present invention is to acute pulpitis patient, and effective percentage is 100%, and cure rate is 95%. This institute's not ability that is current all antiinflammation pain-stopping pharmaceuticals when treating pulpitis and. The present invention acute pulpitis to causing because of plus caries or thus have evolved into the patient of chronic pulpitis and be only capable of relief of symptoms. Therefore this kind of patient after opening marrow treatment, then need to coordinate and take medicine of the present invention, just has best curative effect.

The preparation method of medicine of the present invention is very simple, namely under aseptic technique, by each drug component, after weighing by its proportional quantity, pulverizes, mixes, loads capsule. Every capsules is containing 0.25 gram of medicated powder. Medicine of the present invention also can make tablet according to conventional formulation method.

Usage and dosage: be grown up each 2, three times on the one. Child takes the circumstances into consideration decrement. Can add at midnight when night, pain was serious and take once or once took by 6 hours.

Medicine of the present invention is applicable to acute pulpitis, scorching around apex of root of tooth. Additionally treatment supraorbital neuralgia, cerebrovascular tension force increasing property migraine are also had good curative effect by it.

Poisonous side effect of medicine of the present invention is less, but owing to it includes metronidazole composition, therefore women gestation should be avoided taking for a long time. A few patients is even after taking flushing, heating sense, generally need not drug withdrawal, this symptom would generally quickly disappear.

Detailed description of the invention

Embodiment 1

Weigh nicotinic acid 40mg, bar frustrates 20mg, chlorphenamine 3mg, dexamethasone 1.5mg, phenytoin Sodium 30mg, vitamin B i5mg, first nitre frustrate 400mg, vitamin B₂2mg, vitamin B₆2mg;

Said medicine component is pulverized, mix homogeneously, load in capsulae vacuus. Every capsules is containing 0.25 gram of medicated powder.

Claims (2)

1. the pharmaceutical composition for pulpitis, it is characterised in that it is by the component including following weight portion:

20 40 parts of nicotinic acid, bendazol 10 20 parts, chlorphenamine 13 parts, dexamethasone 0.5 1.5 parts, phenytoin Sodium 15 30 parts, Wei Shengsushi 5 10 parts, metronidazole 200 400 parts.

2. the pharmaceutical composition for pulpitis according to claim 1, it is characterised in that it also includes the component of following weight portion: vitamin B₂2 10 parts, vitamin B₆2 10 parts.